{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T13:01:35Z","timestamp":1793883695851,"version":"4.7.0"},"reference-count":142,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological Psychiatry"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.biopsych.2017.03.003","type":"journal-article","created":{"date-parts":[[2017,3,14]],"date-time":"2017-03-14T21:02:46Z","timestamp":1489525366000},"page":"347-357","source":"Crossref","is-referenced-by-count":361,"title":["Apolipoprotein E, Receptors, and Modulation of Alzheimer\u2019s Disease"],"prefix":"10.1016","volume":"83","author":[{"given":"Na","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Chen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhui","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guojun","family":"Bu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopsych.2017.03.003_bib1","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0140-6736(06)69113-7","article-title":"Alzheimer\u2019s disease","volume":"368","author":"Blennow","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.biopsych.2017.03.003_bib2","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.1072994","article-title":"The amyloid hypothesis of Alzheimer\u2019s disease: Progress and problems on the road to therapeutics","volume":"297","author":"Hardy","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.biopsych.2017.03.003_bib3","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.neurobiolaging.2005.03.016","article-title":"Effects of intranasal insulin on cognition in memory-impaired older adults: Modulation by APOE genotype","volume":"27","author":"Reger","year":"2006","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.biopsych.2017.03.003_bib4","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1126\/science.1197623","article-title":"Decreased clearance of CNS beta-amyloid in Alzheimer\u2019s disease","volume":"330","author":"Mawuenyega","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.biopsych.2017.03.003_bib5","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1126\/science.8346443","article-title":"Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer\u2019s disease in late onset families","volume":"261","author":"Corder","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.biopsych.2017.03.003_bib6","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/nrn2620","article-title":"Apolipoprotein E and its receptors in Alzheimer\u2019s disease: Pathways, pathogenesis and therapy","volume":"10","author":"Bu","year":"2009","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.biopsych.2017.03.003_bib7","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.neuron.2014.01.045","article-title":"ApoE and Abeta in Alzheimer\u2019s disease: Accidental encounters or partners?","volume":"81","author":"Kanekiyo","year":"2014","journal-title":"Neuron"},{"key":"10.1016\/j.biopsych.2017.03.003_bib8","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nrneurol.2012.263","article-title":"Apolipoprotein E and Alzheimer disease: Risk, mechanisms and therapy","volume":"9","author":"Liu","year":"2013","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.biopsych.2017.03.003_bib9","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1126\/science.3283935","article-title":"Apolipoprotein E: Cholesterol transport protein with expanding role in cell biology","volume":"240","author":"Mahley","year":"1988","journal-title":"Science"},{"key":"10.1016\/j.biopsych.2017.03.003_bib10","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1146\/annurev.genom.1.1.507","article-title":"Apolipoprotein E: Far more than a lipid transport protein","volume":"1","author":"Mahley","year":"2000","journal-title":"Annu Rev Genomics Hum Genet"},{"key":"10.1016\/j.biopsych.2017.03.003_bib11","doi-asserted-by":"crossref","first-page":"9077","DOI":"10.1016\/S0021-9258(19)52510-8","article-title":"Human E apoprotein heterogeneity. Cysteine-arginine interchanges in the amino acid sequence of the apo-E isoforms","volume":"256","author":"Weisgraber","year":"1981","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.biopsych.2017.03.003_bib12","doi-asserted-by":"crossref","first-page":"4985","DOI":"10.1523\/JNEUROSCI.5476-05.2006","article-title":"Profile and regulation of apolipoprotein E (ApoE) expression in the CNS in mice with targeting of green fluorescent protein gene to the ApoE locus","volume":"26","author":"Xu","year":"2006","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.biopsych.2017.03.003_bib13","doi-asserted-by":"crossref","first-page":"14208","DOI":"10.1074\/jbc.M114.625251","article-title":"Apolipoprotein E inhibits cerebrovascular pericyte mobility through a RhoA protein-mediated pathway","volume":"290","author":"Casey","year":"2015","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.biopsych.2017.03.003_bib14","doi-asserted-by":"crossref","first-page":"3621","DOI":"10.1523\/JNEUROSCI.4213-04.2005","article-title":"Apolipoprotein E genotype regulates amyloid-beta cytotoxicity","volume":"25","author":"Wilhelmus","year":"2005","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.biopsych.2017.03.003_bib15","doi-asserted-by":"crossref","first-page":"40987","DOI":"10.1074\/jbc.M407963200","article-title":"ABCA1 is required for normal central nervous system ApoE levels and for lipidation of astrocyte-secreted apoE","volume":"279","author":"Wahrle","year":"2004","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.biopsych.2017.03.003_bib16","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/S0022-2275(20)42621-5","article-title":"Apolipoprotein E distribution among human plasma lipoproteins: Role of the cysteine-arginine interchange at residue 112","volume":"31","author":"Weisgraber","year":"1990","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.biopsych.2017.03.003_bib17","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.neuron.2009.06.026","article-title":"The role of apolipoprotein E in Alzheimer\u2019s disease","volume":"63","author":"Kim","year":"2009","journal-title":"Neuron"},{"key":"10.1016\/j.biopsych.2017.03.003_bib18","doi-asserted-by":"crossref","first-page":"10141","DOI":"10.1523\/JNEUROSCI.1054-16.2016","article-title":"Genetic restoration of plasma apoE improves cognition and partially restores synaptic defects in apoE-deficient mice","volume":"36","author":"Lane-Donovan","year":"2016","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.biopsych.2017.03.003_bib19","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1172\/JCI115288","article-title":"Phenotypes of apolipoprotein B and apolipoprotein E after liver transplantation","volume":"88","author":"Linton","year":"1991","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.biopsych.2017.03.003_bib20","doi-asserted-by":"crossref","first-page":"27204","DOI":"10.1074\/jbc.M116.721779","article-title":"Human central nervous system (CNS) apoE isoforms are increased by age, differentially altered by amyloidosis, and relative amounts reversed in the CNS compared to plasma","volume":"291","author":"Baker-Nigh","year":"2016","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.biopsych.2017.03.003_bib21","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/ana.24326","article-title":"Plasma levels of apolipoprotein E and risk of dementia in the general population","volume":"77","author":"Rasmussen","year":"2015","journal-title":"Ann Neurol"},{"key":"10.1016\/j.biopsych.2017.03.003_bib22","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1161\/ATVBAHA.116.307023","article-title":"Central nervous system lipoproteins: ApoE and regulation of cholesterol metabolism","volume":"36","author":"Mahley","year":"2016","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.biopsych.2017.03.003_bib23","doi-asserted-by":"crossref","first-page":"11445","DOI":"10.1523\/JNEUROSCI.1972-08.2008","article-title":"Impact of apolipoprotein E (ApoE) polymorphism on brain ApoE levels","volume":"28","author":"Riddell","year":"2008","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.biopsych.2017.03.003_bib24","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1750-1326-8-13","article-title":"In\u00a0vivo measurement of apolipoprotein E from the brain interstitial fluid using microdialysis","volume":"8","author":"Ulrich","year":"2013","journal-title":"Mol Neurodegener"},{"key":"10.1016\/j.biopsych.2017.03.003_bib25","doi-asserted-by":"crossref","first-page":"50380","DOI":"10.1074\/jbc.M204898200","article-title":"Apolipoprotein E4 forms a molten globule. A potential basis for its association with disease","volume":"277","author":"Morrow","year":"2002","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.biopsych.2017.03.003_bib26","doi-asserted-by":"crossref","first-page":"10658","DOI":"10.1523\/JNEUROSCI.1922-05.2005","article-title":"Effect of domain interaction on apolipoprotein E levels in mouse brain","volume":"25","author":"Ramaswamy","year":"2005","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.biopsych.2017.03.003_bib27","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1194\/jlr.M500114-JLR200","article-title":"The apoE isoform binding properties of the\u00a0VLDL receptor reveal marked differences from LRP and the LDL receptor","volume":"46","author":"Ruiz","year":"2005","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.biopsych.2017.03.003_bib28","doi-asserted-by":"crossref","first-page":"10160","DOI":"10.1016\/S0021-9258(18)82186-X","article-title":"Role of heparan sulfate proteoglycans in the binding and uptake of apolipoprotein E-enriched remnant lipoproteins by cultured cells","volume":"268","author":"Ji","year":"1993","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.biopsych.2017.03.003_bib29","doi-asserted-by":"crossref","first-page":"14782","DOI":"10.1074\/jbc.M213207200","article-title":"Characterization of the heparin binding sites in human apolipoprotein E","volume":"278","author":"Saito","year":"2003","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.biopsych.2017.03.003_bib30","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1172\/JCI110330","article-title":"Familial dysbetalipoproteinemia. Abnormal binding of mutant apoprotein E to low density lipoprotein receptors of human fibroblasts and membranes from liver and adrenal of rats, rabbits, and cows","volume":"68","author":"Schneider","year":"1981","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.biopsych.2017.03.003_bib31","doi-asserted-by":"crossref","first-page":"10771","DOI":"10.1016\/S0021-9258(18)87014-4","article-title":"Opposing effects of apolipoproteins E and C on lipoprotein binding to low density lipoprotein receptor-related protein","volume":"265","author":"Kowal","year":"1990","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.biopsych.2017.03.003_bib32","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1212\/WNL.0000000000003234","article-title":"Relative effect of APOE epsilon4 on neuroimaging biomarker changes across the lifespan","volume":"87","author":"Gonneaud","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.biopsych.2017.03.003_bib33","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1212\/WNL.0b013e31824365ab","article-title":"APOE modifies the association between Abeta load and cognition in cognitively normal older adults","volume":"78","author":"Kantarci","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.biopsych.2017.03.003_bib34","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.neuroimage.2013.04.048","article-title":"Mapping the effects of ApoE4, age and cognitive status on 18F-florbetapir PET measured regional cortical patterns of beta-amyloid density and growth","volume":"78","author":"Murphy","year":"2013","journal-title":"Neuroimage"},{"key":"10.1016\/j.biopsych.2017.03.003_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neurobiolaging.2012.04.017","article-title":"Apolipoprotein E epsilon4 and age effects on florbetapir positron emission tomography in healthy aging and Alzheimer disease","volume":"34","author":"Fleisher","year":"2013","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.biopsych.2017.03.003_bib36","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1002\/ana.24369","article-title":"APOEepsilon2 is associated with milder clinical and pathological Alzheimer disease","volume":"77","author":"Serrano-Pozo","year":"2015","journal-title":"Ann Neurol"},{"key":"10.1016\/j.biopsych.2017.03.003_bib37","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1212\/01.wnl.0000343853.00346.a4","article-title":"APOE epsilon2 is associated with intact cognition but increased Alzheimer pathology in the oldest old","volume":"72","author":"Berlau","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.biopsych.2017.03.003_bib38","doi-asserted-by":"crossref","first-page":"15181","DOI":"10.1523\/JNEUROSCI.1542-12.2012","article-title":"Apolipoprotein E, especially apolipoprotein E4, increases the oligomerization of amyloid beta peptide","volume":"32","author":"Hashimoto","year":"2012","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.biopsych.2017.03.003_bib39","doi-asserted-by":"crossref","first-page":"810981","DOI":"10.4061\/2011\/810981","article-title":"Introducing human APOE into Abeta transgenic mouse models","volume":"2011","author":"Tai","year":"2011","journal-title":"Int J Alzheimers Dis"},{"key":"10.1016\/j.biopsych.2017.03.003_bib40","doi-asserted-by":"crossref","first-page":"212ra161","DOI":"10.1126\/scitranslmed.3007000","article-title":"Gene transfer of human Apoe isoforms results in differential modulation of amyloid deposition and neurotoxicity in mouse brain","volume":"5","author":"Hudry","year":"2013","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.biopsych.2017.03.003_bib41","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1093\/hmg\/ddt525","article-title":"Human APOE genotype affects intraneuronal Abeta1-42 accumulation in a lentiviral gene transfer model","volume":"23","author":"Zhao","year":"2014","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.biopsych.2017.03.003_bib42","doi-asserted-by":"crossref","first-page":"41774","DOI":"10.1074\/jbc.M112.407957","article-title":"APOE4-specific changes in Abeta accumulation in a new transgenic mouse model of Alzheimer disease","volume":"287","author":"Youmans","year":"2012","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.biopsych.2017.03.003_bib43","doi-asserted-by":"crossref","first-page":"6323","DOI":"10.1021\/bi5008172","article-title":"The binding of apolipoprotein E to oligomers and fibrils of amyloid-beta alters the kinetics of amyloid aggregation","volume":"53","author":"Garai","year":"2014","journal-title":"Biochemistry"},{"key":"10.1016\/j.biopsych.2017.03.003_bib44","doi-asserted-by":"crossref","first-page":"12623","DOI":"10.1021\/bi961074j","article-title":"Seeding of A beta fibril formation is inhibited by all three isotypes of apolipoprotein E","volume":"35","author":"Wood","year":"1996","journal-title":"Biochemistry"},{"key":"10.1016\/j.biopsych.2017.03.003_bib45","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S1474-4422(03)00530-1","article-title":"CSF markers for incipient Alzheimer\u2019s disease","volume":"2","author":"Blennow","year":"2003","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.biopsych.2017.03.003_bib46","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1212\/01.WNL.0000128088.08695.05","article-title":"APOE epsilon4 allele is associated with reduced cerebrospinal fluid levels of Abeta42","volume":"62","author":"Prince","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.biopsych.2017.03.003_bib47","doi-asserted-by":"crossref","first-page":"89ra57","DOI":"10.1126\/scitranslmed.3002156","article-title":"Human apoE isoforms differentially regulate brain amyloid-beta peptide clearance","volume":"3","author":"Castellano","year":"2011","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.biopsych.2017.03.003_bib48","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1001\/jamapsychiatry.2014.1060","article-title":"Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease","volume":"71","author":"Lautner","year":"2014","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.biopsych.2017.03.003_bib49","doi-asserted-by":"crossref","first-page":"4558","DOI":"10.1093\/hmg\/dds296","article-title":"Cerebrospinal fluid APOE levels: An endophenotype for\u00a0genetic studies for Alzheimer\u2019s disease","volume":"21","author":"Cruchaga","year":"2012","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.biopsych.2017.03.003_bib50","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1007\/s00401-013-1236-0","article-title":"CSF Apo-E levels associate with cognitive decline and MRI changes","volume":"127","author":"Toledo","year":"2014","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.biopsych.2017.03.003_bib51","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/S0896-6273(03)00124-7","article-title":"APP processing and synaptic function","volume":"37","author":"Kamenetz","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.biopsych.2017.03.003_bib52","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.nbd.2008.04.006","article-title":"LRP1 modulates APP trafficking along early compartments of the secretory pathway","volume":"31","author":"Waldron","year":"2008","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.biopsych.2017.03.003_bib53","doi-asserted-by":"crossref","first-page":"4259","DOI":"10.1523\/JNEUROSCI.5451-03.2004","article-title":"FE65 constitutes the functional link between the low-density lipoprotein receptor-related protein and the amyloid precursor protein","volume":"24","author":"Pietrzik","year":"2004","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.biopsych.2017.03.003_bib54","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1073\/pnas.0305803101","article-title":"Increased soluble amyloid-beta peptide and memory deficits in amyloid model mice overexpressing the low-density lipoprotein receptor-related protein","volume":"101","author":"Zerbinatti","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biopsych.2017.03.003_bib55","doi-asserted-by":"crossref","first-page":"5691","DOI":"10.1093\/emboj\/cdf568","article-title":"The cytoplasmic domain of the LDL receptor-related protein regulates multiple steps in APP processing","volume":"21","author":"Pietrzik","year":"2002","journal-title":"EMBO J"},{"key":"10.1016\/j.biopsych.2017.03.003_bib56","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.neuron.2014.08.048","article-title":"Deficiency in LRP6-mediated Wnt signaling contributes to synaptic abnormalities and amyloid pathology in Alzheimer\u2019s disease","volume":"84","author":"Liu","year":"2014","journal-title":"Neuron"},{"key":"10.1016\/j.biopsych.2017.03.003_bib57","doi-asserted-by":"crossref","first-page":"18700","DOI":"10.1073\/pnas.0508693102","article-title":"Apolipoprotein (apo) E4 enhances amyloid beta peptide production in cultured neuronal cells: ApoE structure as a potential\u00a0therapeutic target","volume":"102","author":"Ye","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biopsych.2017.03.003_bib58","doi-asserted-by":"crossref","first-page":"239","DOI":"10.3233\/JAD-2011-102115","article-title":"The impact of a novel apolipoprotein E and amyloid-beta protein precursor-interacting protein on the production of amyloid-beta","volume":"26","author":"Hopkins","year":"2011","journal-title":"J\u00a0Alzheimers Dis"},{"key":"10.1016\/j.biopsych.2017.03.003_bib59","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.cell.2016.12.044","article-title":"ApoE2, apoE3, and apoE4 differentially stimulate APP transcription and Abeta secretion","volume":"168","author":"Huang","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.biopsych.2017.03.003_bib60","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/nrneurol.2015.119","article-title":"Clearance systems in the brain-implications for Alzheimer disease","volume":"11","author":"Tarasoff-Conway","year":"2015","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.biopsych.2017.03.003_bib61","doi-asserted-by":"crossref","first-page":"e11884","DOI":"10.1371\/journal.pone.0011884","article-title":"Low-density lipoprotein receptor-related protein 1 (LRP1) mediates neuronal Abeta42 uptake and lysosomal trafficking","volume":"5","author":"Fuentealba","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.biopsych.2017.03.003_bib62","doi-asserted-by":"crossref","first-page":"19276","DOI":"10.1523\/JNEUROSCI.3487-13.2013","article-title":"Neuronal clearance of amyloid-beta by endocytic receptor LRP1","volume":"33","author":"Kanekiyo","year":"2013","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.biopsych.2017.03.003_bib63","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/alzrt110","article-title":"Reduction of low-density lipoprotein receptor-related protein (LRP1) in hippocampal neurons does not proportionately reduce, or otherwise alter, amyloid deposition in APPswe\/PS1dE9 transgenic mice","volume":"4","author":"Xu","year":"2012","journal-title":"Alzheimers Res Ther"},{"key":"10.1016\/j.biopsych.2017.03.003_bib64","doi-asserted-by":"crossref","first-page":"16458","DOI":"10.1523\/JNEUROSCI.3987-12.2012","article-title":"LRP1 in brain\u00a0vascular smooth muscle cells mediates local clearance of Alzheimer\u2019s amyloid-beta","volume":"32","author":"Kanekiyo","year":"2012","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.biopsych.2017.03.003_bib65","doi-asserted-by":"crossref","first-page":"2323.e1","DOI":"10.1016\/j.neurobiolaging.2010.05.025","article-title":"LRP1 mediates bidirectional transcytosis of amyloid-beta across the blood-brain barrier","volume":"32","author":"Pflanzner","year":"2011","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.biopsych.2017.03.003_bib66","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1172\/JCI81108","article-title":"Endothelial LRP1 transports amyloid-beta(1-42) across the blood-brain barrier","volume":"126","author":"Storck","year":"2016","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.biopsych.2017.03.003_bib67","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1007\/s11064-006-9084-0","article-title":"Is the LDL receptor involved in cortical amyloid protein clearance?","volume":"31","author":"Abdulkarim","year":"2006","journal-title":"Neurochem Res"},{"key":"10.1016\/j.biopsych.2017.03.003_bib68","doi-asserted-by":"crossref","first-page":"13959","DOI":"10.1074\/jbc.M111.288746","article-title":"Low-density lipoprotein receptor represents an apolipoprotein E-independent pathway of Abeta uptake and degradation by astrocytes","volume":"287","author":"Basak","year":"2012","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.biopsych.2017.03.003_bib69","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3233\/JAD-132228","article-title":"Increased susceptibility to amyloid-beta-induced neurotoxicity in mice lacking the low-density lipoprotein receptor","volume":"41","author":"de Oliveira","year":"2014","journal-title":"J\u00a0Alzheimers Dis"},{"key":"10.1016\/j.biopsych.2017.03.003_bib70","doi-asserted-by":"crossref","first-page":"e21880","DOI":"10.1371\/journal.pone.0021880","article-title":"Lack of LDL receptor enhances amyloid deposition and decreases glial response in an Alzheimer\u2019s disease mouse model","volume":"6","author":"Katsouri","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.biopsych.2017.03.003_bib71","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.neuron.2009.11.013","article-title":"Overexpression of low-density lipoprotein receptor in the brain markedly inhibits amyloid deposition and increases extracellular A beta clearance","volume":"64","author":"Kim","year":"2009","journal-title":"Neuron"},{"key":"10.1016\/j.biopsych.2017.03.003_bib72","doi-asserted-by":"crossref","first-page":"15502","DOI":"10.1073\/pnas.1206446109","article-title":"Low-density lipoprotein receptor overexpression enhances the rate of brain-to-blood Abeta clearance in a mouse model of beta-amyloidosis","volume":"109","author":"Castellano","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biopsych.2017.03.003_bib73","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s13024-016-0073-8","article-title":"Heparan sulfate proteoglycans mediate Abeta-induced oxidative stress and hypercontractility in cultured vascular smooth muscle cells","volume":"11","author":"Reynolds","year":"2016","journal-title":"Mol Neurodegener"},{"key":"10.1016\/j.biopsych.2017.03.003_bib74","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1523\/JNEUROSCI.5491-10.2011","article-title":"Heparan sulphate proteoglycan and the low-density lipoprotein receptor-related protein 1 constitute major pathways for neuronal amyloid-beta uptake","volume":"31","author":"Kanekiyo","year":"2011","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.biopsych.2017.03.003_bib75","doi-asserted-by":"crossref","first-page":"332ra344","DOI":"10.1126\/scitranslmed.aad3650","article-title":"Neuronal heparan sulfates promote amyloid pathology by modulating brain amyloid-beta clearance and aggregation in Alzheimer\u2019s disease","volume":"8","author":"Liu","year":"2016","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.biopsych.2017.03.003_bib76","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s13024-016-0099-y","article-title":"Apolipoprotein E lipoprotein particles inhibit amyloid-beta uptake through cell surface heparan sulphate proteoglycan","volume":"11","author":"Fu","year":"2016","journal-title":"Mol Neurodegener"},{"key":"10.1016\/j.biopsych.2017.03.003_bib77","doi-asserted-by":"crossref","first-page":"23403","DOI":"10.1016\/S0021-9258(17)31529-6","article-title":"Isoform-specific binding of apolipoprotein E to beta-amyloid","volume":"269","author":"LaDu","year":"1994","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.biopsych.2017.03.003_bib78","doi-asserted-by":"crossref","first-page":"323","DOI":"10.3233\/JAD-2008-13309","article-title":"Intranasal insulin administration dose-dependently modulates verbal memory and plasma amyloid-beta in memory-impaired older adults","volume":"13","author":"Reger","year":"2008","journal-title":"J\u00a0Alzheimers Dis"},{"key":"10.1016\/j.biopsych.2017.03.003_bib79","doi-asserted-by":"crossref","first-page":"897","DOI":"10.3233\/JAD-141791","article-title":"Long-acting intranasal insulin detemir improves cognition for adults with mild cognitive impairment or early-stage Alzheimer\u2019s disease dementia","volume":"44","author":"Claxton","year":"2015","journal-title":"J\u00a0Alzheimers Dis"},{"key":"10.1016\/j.biopsych.2017.03.003_bib80","doi-asserted-by":"crossref","first-page":"4002","DOI":"10.1172\/JCI36663","article-title":"apoE isoform-specific disruption of amyloid beta peptide clearance from mouse brain","volume":"118","author":"Deane","year":"2008","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.biopsych.2017.03.003_bib81","doi-asserted-by":"crossref","first-page":"E1807","DOI":"10.1073\/pnas.1220484110","article-title":"ApoE influences amyloid-beta (Abeta) clearance despite minimal apoE\/Abeta association in physiological conditions","volume":"110","author":"Verghese","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biopsych.2017.03.003_bib82","doi-asserted-by":"crossref","first-page":"29645","DOI":"10.1074\/jbc.R800022200","article-title":"The AbetaCs of Abeta-cleaving proteases","volume":"283","author":"Leissring","year":"2008","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.biopsych.2017.03.003_bib83","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0074-7742(07)82006-X","article-title":"New insights into the roles of metalloproteinases in neurodegeneration and neuroprotection","volume":"82","author":"Turner","year":"2007","journal-title":"Int Rev Neurobiol"},{"key":"10.1016\/j.biopsych.2017.03.003_bib84","doi-asserted-by":"crossref","first-page":"4162","DOI":"10.1073\/pnas.0230450100","article-title":"Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in\u00a0vivo","volume":"100","author":"Farris","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biopsych.2017.03.003_bib85","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1126\/science.1059946","article-title":"Metabolic regulation of brain Abeta by neprilysin","volume":"292","author":"Iwata","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.biopsych.2017.03.003_bib86","doi-asserted-by":"crossref","first-page":"6221","DOI":"10.1073\/pnas.1031520100","article-title":"Amyloid-beta peptide levels in brain are inversely correlated with insulysin activity levels in\u00a0vivo","volume":"100","author":"Miller","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biopsych.2017.03.003_bib87","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0002-9440(10)63822-9","article-title":"Reduced hippocampal insulin-degrading enzyme in late-onset Alzheimer\u2019s disease is associated with the apolipoprotein E-epsilon4 allele","volume":"162","author":"Cook","year":"2003","journal-title":"Am J Pathol"},{"key":"10.1016\/j.biopsych.2017.03.003_bib88","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.neulet.2009.07.032","article-title":"ApoE 4 reduces the expression of Abeta degrading enzyme IDE by activating the NMDA receptor in hippocampal neurons","volume":"464","author":"Du","year":"2009","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.biopsych.2017.03.003_bib89","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.neuron.2008.04.010","article-title":"ApoE promotes the proteolytic degradation of Abeta","volume":"58","author":"Jiang","year":"2008","journal-title":"Neuron"},{"key":"10.1016\/j.biopsych.2017.03.003_bib90","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.expneurol.2011.11.001","article-title":"The effect of amyloid associated proteins on the expression of genes involved in amyloid-beta clearance by adult human astrocytes","volume":"233","author":"Mulder","year":"2012","journal-title":"Exp Neurol"},{"key":"10.1016\/j.biopsych.2017.03.003_bib91","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/1750-1326-6-63","article-title":"Alzheimer\u2019s disease: Synapses gone cold","volume":"6","author":"Koffie","year":"2011","journal-title":"Mol Neurodegener"},{"key":"10.1016\/j.biopsych.2017.03.003_bib92","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a005777","article-title":"Synapses and Alzheimer\u2019s disease","volume":"4","author":"Sheng","year":"2012","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"10.1016\/j.biopsych.2017.03.003_bib93","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13024-015-0002-2","article-title":"APOE4 enhances age-dependent decline in cognitive function by down-regulating an NMDA receptor pathway in EFAD-Tg mice","volume":"10","author":"Liu","year":"2015","journal-title":"Mol Neurodegener"},{"key":"10.1016\/j.biopsych.2017.03.003_bib94","doi-asserted-by":"crossref","first-page":"3425","DOI":"10.1074\/jbc.M509380200","article-title":"Apolipoprotein E receptor 2 interactions with the N-methyl-D-aspartate receptor","volume":"281","author":"Hoe","year":"2006","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.biopsych.2017.03.003_bib95","doi-asserted-by":"crossref","first-page":"21909","DOI":"10.1074\/jbc.M112.444364","article-title":"Low density lipoprotein receptor-related protein 1 (LRP1) modulates N-methyl-D-aspartate (NMDA) receptor-dependent intracellular signaling and NMDA-induced regulation of postsynaptic protein complexes","volume":"288","author":"Nakajima","year":"2013","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.biopsych.2017.03.003_bib96","doi-asserted-by":"crossref","first-page":"15947","DOI":"10.1074\/jbc.M111.312710","article-title":"Apolipoprotein E3 (ApoE3) but not ApoE4 protects against synaptic loss through increased expression of protein kinase C epsilon","volume":"287","author":"Sen","year":"2012","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.biopsych.2017.03.003_bib97","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1523\/JNEUROSCI.5471-06.2007","article-title":"Apolipoprotein E-containing lipoproteins protect neurons from apoptosis via a signaling pathway involving low-density lipoprotein receptor-related protein-1","volume":"27","author":"Hayashi","year":"2007","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.biopsych.2017.03.003_bib98","doi-asserted-by":"crossref","first-page":"12011","DOI":"10.1073\/pnas.0914984107","article-title":"ApoE4 reduces glutamate receptor function and synaptic plasticity by selectively impairing ApoE receptor recycling","volume":"107","author":"Chen","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biopsych.2017.03.003_bib99","doi-asserted-by":"crossref","first-page":"16697","DOI":"10.1073\/pnas.1008200107","article-title":"Hippocampal long-term depression is required for the consolidation of spatial memory","volume":"107","author":"Ge","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biopsych.2017.03.003_bib100","doi-asserted-by":"crossref","first-page":"789","DOI":"10.3233\/JAD-122308","article-title":"Sex and ApoE genotype differences in treatment response to two doses of intranasal insulin in adults with mild cognitive impairment or Alzheimer\u2019s disease","volume":"35","author":"Claxton","year":"2013","journal-title":"J\u00a0Alzheimers Dis"},{"key":"10.1016\/j.biopsych.2017.03.003_bib101","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1056\/NEJMoa1304839","article-title":"Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer\u2019s disease","volume":"370","author":"Salloway","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.biopsych.2017.03.003_bib102","first-page":"671","article-title":"Overexpression of ABCA1 reduces amyloid deposition in the PDAPP mouse model of Alzheimer disease","volume":"118","author":"Wahrle","year":"2008","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.biopsych.2017.03.003_bib103","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.mcn.2007.01.011","article-title":"The LXR agonist TO901317 selectively lowers hippocampal Abeta42 and improves memory in the Tg2576 mouse model of Alzheimer\u2019s disease","volume":"34","author":"Riddell","year":"2007","journal-title":"Mol Cell Neurosci"},{"key":"10.1016\/j.biopsych.2017.03.003_bib104","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S1097-2765(01)00164-2","article-title":"A\u00a0PPAR gamma-LXR-ABCA1 pathway in macrophages is involved in cholesterol efflux and atherogenesis","volume":"7","author":"Chawla","year":"2001","journal-title":"Mol Cell"},{"key":"10.1016\/j.biopsych.2017.03.003_bib105","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1126\/science.1217697","article-title":"ApoE-directed therapeutics rapidly clear beta-amyloid and reverse deficits in AD mouse models","volume":"335","author":"Cramer","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.biopsych.2017.03.003_bib106","doi-asserted-by":"crossref","DOI":"10.1126\/science.1235505","article-title":"Comment on \u201cApoE-directed therapeutics rapidly clear beta-amyloid and reverse deficits in AD mouse models\u201d","volume":"340","author":"Veeraraghavalu","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.biopsych.2017.03.003_bib107","doi-asserted-by":"crossref","DOI":"10.1126\/science.1233937","article-title":"Comment on \u201cApoE-directed therapeutics rapidly clear beta-amyloid and reverse deficits in AD mouse models\u201d","volume":"340","author":"Tesseur","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.biopsych.2017.03.003_bib108","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.expneurol.2015.12.003","article-title":"Rescuing effects of RXR agonist bexarotene on aging-related synapse loss depend on neuronal LRP1","volume":"277","author":"Tachibana","year":"2016","journal-title":"Exp Neurol"},{"key":"10.1016\/j.biopsych.2017.03.003_bib109","doi-asserted-by":"crossref","first-page":"7293","DOI":"10.1523\/JNEUROSCI.5198-13.2014","article-title":"Reversal of apoE4-driven brain pathology and behavioral deficits by bexarotene","volume":"34","author":"Boehm-Cagan","year":"2014","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.biopsych.2017.03.003_bib110","doi-asserted-by":"crossref","first-page":"30538","DOI":"10.1074\/jbc.M114.600833","article-title":"Amyloid-beta pathology and APOE genotype modulate retinoid X receptor agonist activity in\u00a0vivo","volume":"289","author":"Tai","year":"2014","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.biopsych.2017.03.003_bib111","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.neuropharm.2016.04.032","article-title":"Quercetin stabilizes apolipoprotein E and reduces brain Abeta levels in amyloid model mice","volume":"108","author":"Zhang","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.biopsych.2017.03.003_bib112","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jconrel.2009.03.002","article-title":"Albumin nanoparticles targeted with Apo E enter the CNS by transcytosis and are delivered to neurones","volume":"137","author":"Zensi","year":"2009","journal-title":"J\u00a0Control Release"},{"key":"10.1016\/j.biopsych.2017.03.003_bib113","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s13024-015-0001-3","article-title":"Opposing effects of viral mediated brain expression of apolipoprotein E2 (apoE2) and apoE4 on apoE lipidation and Abeta metabolism in apoE4-targeted replacement mice","volume":"10","author":"Hu","year":"2015","journal-title":"Mol Neurodegener"},{"key":"10.1016\/j.biopsych.2017.03.003_bib114","doi-asserted-by":"crossref","first-page":"4803","DOI":"10.1523\/JNEUROSCI.0033-12.2012","article-title":"Reducing human apolipoprotein E levels attenuates age-dependent Abeta accumulation in mutant human amyloid precursor protein transgenic mice","volume":"32","author":"Bien-Ly","year":"2012","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.biopsych.2017.03.003_bib115","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1084\/jem.20121274","article-title":"Anti-apoE immunotherapy inhibits amyloid accumulation in a\u00a0transgenic mouse model of Abeta amyloidosis","volume":"209","author":"Kim","year":"2012","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.biopsych.2017.03.003_bib116","doi-asserted-by":"crossref","first-page":"7281","DOI":"10.1523\/JNEUROSCI.0646-14.2014","article-title":"Anti-ApoE antibody given after plaque onset decreases Abeta accumulation and improves brain function in a mouse model of Abeta amyloidosis","volume":"34","author":"Liao","year":"2014","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.biopsych.2017.03.003_bib117","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1001\/jamaneurol.2014.2011","article-title":"Effects of the absence of apolipoprotein e on lipoproteins, neurocognitive function, and retinal function","volume":"71","author":"Mak","year":"2014","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.biopsych.2017.03.003_bib118","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jalz.2008.01.006","article-title":"Apolipoprotein E4 domain interaction: Synaptic and cognitive deficits in mice","volume":"4","author":"Zhong","year":"2008","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.biopsych.2017.03.003_bib119","doi-asserted-by":"crossref","first-page":"8997","DOI":"10.1021\/jm3008618","article-title":"Small-molecule structure correctors target abnormal protein structure and function: Structure corrector rescue of apolipoprotein E4-associated neuropathology","volume":"55","author":"Mahley","year":"2012","journal-title":"J\u00a0Med Chem"},{"key":"10.1016\/j.biopsych.2017.03.003_bib120","doi-asserted-by":"crossref","first-page":"5253","DOI":"10.1074\/jbc.M111.276162","article-title":"Small molecule structure correctors abolish detrimental effects of apolipoprotein E4 in cultured neurons","volume":"287","author":"Chen","year":"2012","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.biopsych.2017.03.003_bib121","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1038\/nbt.3155","article-title":"Inducible in\u00a0vivo genome editing with CRISPR-Cas9","volume":"33","author":"Dow","year":"2015","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.biopsych.2017.03.003_bib122","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1750-1326-9-11","article-title":"ApoE variant p.V236E is associated with markedly reduced risk of Alzheimer\u2019s disease","volume":"9","author":"Medway","year":"2014","journal-title":"Mol Neurodegener"},{"key":"10.1016\/j.biopsych.2017.03.003_bib123","doi-asserted-by":"crossref","first-page":"8913","DOI":"10.1073\/pnas.1207022109","article-title":"Structural differences between apoE3 and\u00a0apoE4 may be useful in developing therapeutic agents for Alzheimer\u2019s disease","volume":"109","author":"Frieden","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biopsych.2017.03.003_bib124","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.jmb.2006.06.080","article-title":"Amino-terminal domain stability mediates apolipoprotein E aggregation into neurotoxic fibrils","volume":"361","author":"Hatters","year":"2006","journal-title":"J\u00a0Mol Biol"},{"key":"10.1016\/j.biopsych.2017.03.003_bib125","doi-asserted-by":"crossref","first-page":"6771","DOI":"10.1523\/JNEUROSCI.0887-09.2009","article-title":"Human APOE isoform-dependent effects on brain beta-amyloid levels in PDAPP transgenic mice","volume":"29","author":"Bales","year":"2009","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.biopsych.2017.03.003_bib126","doi-asserted-by":"crossref","first-page":"18787","DOI":"10.1073\/pnas.0604011103","article-title":"Blocking the apolipoprotein E\/amyloid-beta interaction as a potential therapeutic approach for Alzheimer\u2019s disease","volume":"103","author":"Sadowski","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biopsych.2017.03.003_bib127","first-page":"75","article-title":"Blocking the apoE\/Abeta interaction ameliorates Abeta-related pathology in APOE epsilon2 and epsilon4 targeted replacement Alzheimer model mice","volume":"2","author":"Pankiewicz","year":"2014","journal-title":"Acta Neuropathol Commun"},{"key":"10.1016\/j.biopsych.2017.03.003_bib128","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1159\/000334914","article-title":"APOE-mimetic peptides reduce behavioral deficits, plaques and tangles in Alzheimer\u2019s disease transgenics","volume":"10","author":"Vitek","year":"2012","journal-title":"Neurodegener Dis"},{"key":"10.1016\/j.biopsych.2017.03.003_bib129","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/nrm.2015.27","article-title":"Pluripotent stem cells in disease modelling and drug discovery","volume":"17","author":"Avior","year":"2016","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.biopsych.2017.03.003_bib130","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.neurobiolaging.2005.04.008","article-title":"Premorbid effects of APOE on synaptic proteins in human temporal neocortex","volume":"27","author":"Love","year":"2006","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.biopsych.2017.03.003_bib131","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1074\/mcp.M115.056580","article-title":"Apolipoprotein E*4 (APOE*4) genotype is associated with altered levels of glutamate signaling proteins and synaptic coexpression networks in the prefrontal cortex in mild to moderate Alzheimer disease","volume":"15","author":"Sweet","year":"2016","journal-title":"Mol Cell Proteomics"},{"key":"10.1016\/j.biopsych.2017.03.003_bib132","doi-asserted-by":"crossref","first-page":"6580","DOI":"10.1038\/srep06580","article-title":"Reduced neuronal signaling in the ageing apolipoprotein-E4 targeted replacement female mice","volume":"4","author":"Yong","year":"2014","journal-title":"Sci Rep"},{"key":"10.1016\/j.biopsych.2017.03.003_bib133","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.neuroscience.2003.08.007","article-title":"Apolipoprotein E isoform-specific regulation of dendritic spine morphology in apolipoprotein E transgenic mice and Alzheimer\u2019s disease patients","volume":"122","author":"Ji","year":"2003","journal-title":"Neuroscience"},{"key":"10.1016\/j.biopsych.2017.03.003_bib134","doi-asserted-by":"crossref","first-page":"15317","DOI":"10.1523\/JNEUROSCI.4026-09.2009","article-title":"ApoE4 decreases spine density and dendritic complexity in cortical neurons in\u00a0vivo","volume":"29","author":"Dumanis","year":"2009","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.biopsych.2017.03.003_bib135","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/j.neuroscience.2010.10.027","article-title":"Progressive loss of synaptic integrity in human apolipoprotein E4 targeted replacement mice and attenuation by apolipoprotein E2","volume":"171","author":"Klein","year":"2010","journal-title":"Neuroscience"},{"key":"10.1016\/j.biopsych.2017.03.003_bib136","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.nbd.2004.10.013","article-title":"Human apoE4-targeted replacement mice display synaptic deficits in the absence of neuropathology","volume":"18","author":"Wang","year":"2005","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.biopsych.2017.03.003_bib137","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1016\/j.neurobiolaging.2014.02.019","article-title":"Altered neurotransmission in the lateral amygdala in aged human apoE4 targeted replacement mice","volume":"35","author":"Klein","year":"2014","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.biopsych.2017.03.003_bib138","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.neulet.2004.07.084","article-title":"Age-dependent enhancement of hippocampal long-term potentiation in knock-in mice expressing human apolipoprotein E4 instead of mouse apolipoprotein E","volume":"369","author":"Kitamura","year":"2004","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.biopsych.2017.03.003_bib139","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1750-1326-4-21","article-title":"ApoE isoform-dependent changes in hippocampal synaptic function","volume":"4","author":"Korwek","year":"2009","journal-title":"Mol Neurodegener"},{"key":"10.1016\/j.biopsych.2017.03.003_bib140","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1097\/00001756-200412030-00020","article-title":"ApoE isoform affects LTP in human targeted replacement mice","volume":"15","author":"Trommer","year":"2004","journal-title":"Neuroreport"},{"key":"10.1016\/j.biopsych.2017.03.003_bib141","first-page":"75","article-title":"ApoE isoform-specific effects on LTP: Blockade by oligomeric amyloid-beta1-42","volume":"18","author":"Trommer","year":"2005","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.biopsych.2017.03.003_bib142","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/nature11087","article-title":"Apolipoprotein E controls cerebrovascular integrity via cyclophilin A","volume":"485","author":"Bell","year":"2012","journal-title":"Nature"}],"container-title":["Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006322317313586?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006322317313586?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,22]],"date-time":"2024-06-22T19:54:02Z","timestamp":1719086042000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006322317313586"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":142,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["S0006322317313586"],"URL":"https:\/\/doi.org\/10.1016\/j.biopsych.2017.03.003","relation":{},"ISSN":["0006-3223"],"issn-type":[{"value":"0006-3223","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]}}}